Sponsored Newsletter
Join STATinMED at Booth 510!
Published Oct. 6, 2022
Sponsored Newsletter
LIVE NEXT WEEK | Making HEOR More Accessible to Patients
Published Oct. 5, 2022
General Newsletter
Issue
623
Generics Companies Considering EU Cuts; Medicare 340B Brawl Drags On; Lecanemab May Skirt Aduhelm's CMS Fate
Published Oct. 4, 2022
Sponsored Newsletter
LIVE WEBINAR | Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Published Oct. 3, 2022
Sponsored Newsletter
New Webinar! Future direction of interactive tools for health technology assessment: LiveBIM, LiveOS, LiveUtility, & LiveCEM
Published Sep. 30, 2022
Sponsored Newsletter
Accelerate your RWE goals with Veradigm
Published Sep. 29, 2022
Sponsored Newsletter
October 20 webinar | Syapse partnership | New CFO | ISPOR Europe Info
Published Sep. 28, 2022
General Newsletter
Issue
622
$3 M Gene Therapies May Become the Norm; Novartis Leans into US Market; Pfizer Extends $110 M RWD AI Drug Development Deal
Published Sep. 27, 2022
Sponsored Newsletter
Using HEOR data to launch therapies more effectively
Published Sep. 26, 2022
Sponsored Newsletter
UPCOMING | Making HEOR More Accessible to Patients
Published Sep. 23, 2022
Sponsored Newsletter
NEXT WEEK | An Introduction to Infectious Disease Modeling
Published Sep. 22, 2022
Sponsored Newsletter
Cytel Webinar Series Alert! LiveHTA: Concept or Reality?
Published Sep. 21, 2022
General Newsletter
Issue
621
EU Approves Novavax COVID-19 Boosters; Novartis Case Dismissed Again; Bayer Begins New CEO Search
Published Sep. 20, 2022
Sponsored Newsletter
Xcenda’s HTA Quarterly examines new EU regulation on health technology assessment
Published Sep. 19, 2022
Sponsored Newsletter
Halve your workload and drive better cancer care
Published Sep. 16, 2022
Sponsored Newsletter
Tap into the Veradigm Network with RWD from the point of care
Published Sep. 15, 2022
Sponsored Newsletter
Your Window into Global Treatment Trends
Published Sep. 14, 2022
